Current studies

The studies listed below are being conducted at Newcastle University, with links to NCMD. They are ongoing and from time to time need people to take part in them. Where this is the case, there is a link showing how you can get involved.

HELIOS-BD

Lithium's mechanism in bipolar disorder: Investigating the light hypersensitivity hypothesis

Supplemental Lithium Imaging, Peripheral Inflammation and Mitochondrial Function (SLIPI-M) study

The SLIPI study will measure the effects of lithium orotate on peripheral biomarkers of inflammation and mitochondrial function on healthy male volunteers aged 18-65 years old.

Cognitive Remediation in Bipolar (CRiB2)

CRiB2 is a study which aims to investigate whether cognitive remediation therapy is effective in improving the thinking skills and daily life functioning of people with bipolar disorder.

COMP 006

The COMP 006 study explores the delivery of an investigational medicine (COMP360) alongside psychological support for the treatment of depression which has not responded to antidepressant treatment.

ASCEnD

ASCEnD is a clinical and cost-effectiveness study of aripiprazole combined with sertraline for patients with bipolar depression. It is running in 10 sites across the UK and recruitment is open now!